Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02901301
Brief Title: Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancer

First Submitted : September 11, 2016
First Submitted that Met QC Criteria : September 14, 2016
First Posted : September 15, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 10, 2020
Last Update Posted : January 14, 2020